Cargando...

C(60) Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment

BACKGROUND: Doxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drugs R D
Main Authors: Prylutska, Svitlana, Grynyuk, Iryna, Matyshevska, Olga, Prylutskyy, Yuriy, Evstigneev, Maxim, Scharff, Peter, Ritter, Uwe
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269825/
https://ncbi.nlm.nih.gov/pubmed/25504158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-014-0074-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!